The Medicines Act 1968 is a piece of legislation enacted by the Parliament of the United Kingdom to establish a comprehensive statutory framework for the control, manufacture, distribution, and supply of medicinal products within Great Britain. The Act received Royal Assent on 16 July 1968 and has been amended numerous times to reflect developments in pharmaceutical science, public health policy, and European Union regulations.
Overview
The Act superseded earlier statutes, notably the Medicines Act 1963, and introduced a modern classification system for medicines, a licensing regime for manufacturers, wholesalers and pharmacists, and provisions concerning the labeling, advertising, and importation of medicinal products. It remains a foundational element of UK drug regulation, although many of its provisions have been incorporated into or superseded by subsequent legislation, such as the Human Medicines Regulations 2012.
Key Provisions
| Provision | Description |
|---|---|
| Classification of medicines | Introduced three principal categories: • Prescription‑only medicines (POM) – available only with a prescription from a qualified prescriber. • Pharmacy medicines (P) – available without a prescription but only from a pharmacy. • General Sale List (GSL) – available for sale without prescription from any retail outlet. |
| Licensing | Requires a Manufacturer’s Licence for the production of medicinal products, a Wholesale Dealer’s Licence for distribution, and a Pharmacy Licence for the sale of medicines. Each licence is subject to inspection and renewal by the competent authority. |
| Labeling and packaging | Mandates that medicinal products bear specific information, including the product name, strength, dosage form, batch number, expiry date, and any necessary warnings. |
| Advertising restrictions | Prohibits misleading or non‑authorised promotion of prescription‑only medicines to the public, while allowing limited advertising of pharmacy and GSL medicines under specified conditions. |
| Import and export controls | Regulates the importation of medicinal products, requiring import licences for non‑domestic items and ensuring conformity with UK standards. |
| Pharmacovigilance | Established obligations for manufacturers and distributors to report adverse drug reactions and maintain records of product safety. |
Administration
Initially, the Act’s enforcement responsibilities were assigned to the Medicines Control Agency (MCA), which later merged with the Medical Devices Agency to form the Medicines and Healthcare products Regulatory Agency (MHRA) in 2003. The MHRA continues to oversee compliance with the Act’s provisions, conduct inspections, and issue licences.
Amendments and Related Legislation
Since 1968, the Act has been amended by a series of statutes and statutory instruments, notably:
- Medicines (Prescription Only) Amendment Regulations 1980 – refined the POM list.
- Medicines Act 1968 (Amendment) Order 1995 – introduced electronic record‑keeping requirements.
- Human Medicines Regulations 2012 – consolidated many provisions of the Medicines Act with EU directives, effectively superseding parts of the 1968 Act while retaining its core classification system.
Impact and Significance
The Medicines Act 1968 established a systematic approach to drug safety, quality, and accessibility in the United Kingdom. Its classification scheme (POM, P, GSL) remains a central reference for healthcare professionals, pharmacies, and the public. The licensing regime introduced by the Act laid the groundwork for rigorous quality assurance in pharmaceutical manufacturing and distribution, contributing to high standards of public health protection.
See also
- Human Medicines Regulations 2012
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Pharmacy (United Kingdom)
References
- Medicines Act 1968, UK Public General Acts. Available at: legislation.gov.uk.
- Medicines and Healthcare products Regulatory Agency, “History of Medicines Regulation in the UK”, MHRA website, accessed June 2026.
- Human Medicines Regulations 2012, UK Statutory Instruments.
Note: The information presented reflects the status of the Medicines Act 1968 as documented in official UK legislative sources and regulatory publications up to June 2026.